Accordingly, an homozygous mouse model with Dmpk disruption has shown some DM1 clinical features, such as progressive weakness, abnormalities in skeletal muscle, skeletal myopathy and dysfunction in cardiac conduction [174,175]. The gene discussed is DMPK; the disease is myotonic dystrophy type 1.